These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6311427)

  • 1. Evaluation of central opioid tonus in menstrual migraine.
    Petraglia F; Martignoni E; Sola D; Cicoli C; Facchinetti F; Nappi G; Genazzani AR
    Cephalalgia; 1983 Aug; 3 Suppl 1():98-100. PubMed ID: 6311427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen changes as a critical factor in modulation of central opioid tonus: possible correlations with post-menopausal migraine.
    Genazzani AR; Petraglia F; Volpe A; Facchinetti F
    Cephalalgia; 1985 May; 5 Suppl 2():212-4. PubMed ID: 2990722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient failure of central opioid tonus and premenstrual symptoms.
    Facchinetti F; Martignoni E; Sola D; Petraglia F; Nappi G; Genazzani AR
    J Reprod Med; 1988 Jul; 33(7):633-8. PubMed ID: 3050071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia.
    Petraglia F; Golinelli S; d'Ambrogio G; Comitini G; Facchinetti F; Volpe A; Genazzani AR
    Gynecol Obstet Invest; 1987; 23(2):117-21. PubMed ID: 3034748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
    Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
    Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endogenous opiates in LH secretion during the menstrual cycle.
    Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1980 Jul; 51(1):179-81. PubMed ID: 7380991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual migraine: a distinct disorder needing greater recognition.
    Vetvik KG; MacGregor EA
    Lancet Neurol; 2021 Apr; 20(4):304-315. PubMed ID: 33600767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of neuroendocrine axes in patients with menstrual migraine.
    Fioroni L; Martignoni E; Facchinetti F
    Cephalalgia; 1995; 15(4):297-300. PubMed ID: 7585927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal influences on serum luteinizing hormone responses to opiate receptor blockade with naloxone or to luteinizing hormone-releasing hormone in the immature female rat.
    Blank MS; Mann DR
    Proc Soc Exp Biol Med; 1981 Dec; 168(3):338-43. PubMed ID: 6275395
    [No Abstract]   [Full Text] [Related]  

  • 14. Migraine and menstruation: a pilot study.
    MacGregor EA; Chia H; Vohrah RC; Wilkinson M
    Cephalalgia; 1990 Dec; 10(6):305-10. PubMed ID: 2289231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological aspects of menstrual migraine.
    Benedetto C; Allais G; Ciochetto D; De Lorenzo C
    Cephalalgia; 1997 Dec; 17 Suppl 20():32-4. PubMed ID: 9496776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine.
    Facchinetti F; Martignoni E; Fioroni L; Sances G; Genazzani AR
    Cephalalgia; 1990 Feb; 10(1):51-6. PubMed ID: 2317851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the menstrual cycle on standard achromatic and blue-on-yellow visual field analysis of women with migraine.
    Yucel I; Akar ME; Dora B; Akar Y; Taskin O; Ozer HO
    Can J Ophthalmol; 2005 Feb; 40(1):51-7. PubMed ID: 15825530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine associated with menstruation.
    MacGregor A
    Funct Neurol; 2000; 15 Suppl 3():143-53. PubMed ID: 11200785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion.
    Masotto C; Negro-Vilar A
    Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.